Highlights Gan & Lee Pharmaceuticals.

Equities

603087

CNE100003ZH1

End-of-day quote Shanghai S.E. Other stock markets 11/09/2024			5-day change	1st Jan Change
38.99 ^CNY	+0.49%		-1.02%	-25.94%

09-06	Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares.	CI
09-05	Gan & Lee Pharmaceuticals. authorizes a Buyback Plan.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares.	09-05	CI
Gan & Lee Pharmaceuticals. authorizes a Buyback Plan.	09-04	CI
Gan & Lee Pharmaceuticals' H1 Profit Soars 123%; Shares Jump 4%	08-29	MT
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Half Year Ended June 30, 2024	08-28	CI
Gan & Lee Pharmaceuticals' Unit Secures Nod to Trial Insulin Injection in US	08-06	MT
Gan & Lee Pharmaceuticals Gets Mexico's Drug Registration Approval for Insulin Glargine Injection	05-24	MT
Gan & Lee Pharmaceuticals. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Gan & Lee Pharma's Insulin Product Gets Registration Approval in Bolivia	01-26	MT
Gan & Lee Pharmaceuticals Administers First Subject in Phase II Study of GZR101 Diabetes Drug	12-12	MT
Gan & Lee Pharmaceuticals' Unit Gets Nod to Test GZR18 Tablets	12-04	MT
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Gan & Lee Pharmaceuticals Gets Nod to Trial GLR1023 Injection	20/07/23	MT
Gan & Lee Pharmaceuticals Gets Regulatory Nod for Private Placement	20/06/23	MT
Pharmaktiv acquired remaining 51% stake in Endogenix LLC from Gan & Lee Pharmaceuticals..	13/06/23	CI
Gan & Lee Pharmaceuticals. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Gan & Lee Pharmaceuticals' Insulin Injection Enters Pakistani Market	09/12/22	MT
Gan & Lee Pharmaceuticals. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Gan & Lee Pharmaceuticals.

Equities

603087

CNE100003ZH1

Highlights

Filters